Viatris recalls

Viatris has 25 recalls on record with the FDA and USDA, the earliest in 2021 and the latest reported on 15 Apr 2026. 12 are still ongoing. 1 was reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls25since 2021

Last 12 months1reported

Class I14% of total

Ongoing12latest 15 Apr 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 11 2 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 1 0May 0 0 0Aug 0 0

Severity split

Class I 1 4%Class II 22 88%Class III 2 8%

Why viatris is recalled

Product types

Brands

By year

202614%
202528%
20241456%
202314%
2022520%
202128%

Ongoing viatris recalls

12 active

Reported	Class	Recall	Company	Reason	Where
15 Apr 2026Drug	CLASS II	Xanax XR, alprazolam, extended-release tablets, 3 mg recalled by ViatrisXanax	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 25 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 75 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 88 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 137 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 175 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide

All viatris recalls, newest first

25 total

Reported	Class	Recall	Company	Reason	Where
15 Apr 2026Drug	CLASS II	Xanax XR, alprazolam, extended-release tablets, 3 mg recalled by ViatrisXanax	Viatris	Potency & Assay	Nationwide
22 Jan 2025Drug	CLASS II	Cardura XL (doxazosin) extended release tablets 4 mg recalled by ViatrisCardura	Viatris	Potency & Assay	Nationwide
22 Jan 2025Drug	CLASS II	Cardura XL (doxazosin) extended release tablets 8 mg recalled by ViatrisCardura	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 25 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 75 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 88 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 137 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 175 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 112 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 200 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 125 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 50 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 100 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
18 Dec 2024Drug	CLASS II	Levothyroxine Sodium Tablets USP, 150 mcg recalled by ViatrisLevothyroxine Sodium	Viatris	Potency & Assay	Nationwide
24 Jul 2024Drug	CLASS II	Cardura XL (doxazosin) extended release tablets 4mg recalled by Viatris	Viatris	Potency & Assay	Nationwide
24 Jul 2024Drug	CLASS II	Cardura XL (doxazosin) extended release tablets 8mg recalled by Viatris	Viatris	Potency & Assay	Nationwide
8 May 2024Drug	CLASS III	Valacyclovir Tablets USP, 500 mg recalled by ViatrisValacyclovir Hydrochloride	Viatris	Other	Nationwide
14 Jun 2023Drug	CLASS II	Levsin injection (hyoscyamine sulfate injection, USP) recalled	Viatris	Manufacturing (CGMP) Deviations	PA
23 Nov 2022Drug	CLASS II	Carvedilol Tablets, USP, 25 mg recalled by Viatris	Viatris	Other	Nationwide
16 Nov 2022Drug	CLASS I	Octreotide Acetate Injection 500 mcg/mL recalled by ViatrisOctreotide Acetate	Viatris	Particulate Matter	Nationwide
5 Oct 2022Drug	CLASS II	Ampicillin for Injection recalled by Viatris	Viatris	Particulate Matter	Nationwide
18 May 2022Drug	CLASS II	Xanax XR (alprazolam) extended-release tablets, 3 mg recalled by Viatris	Viatris	Potency & Assay	Nationwide
11 May 2022Drug	CLASS II	alprazolam XR extended-release tablets, 3 mg recalled by ViatrisAlprazolam	Viatris	Potency & Assay	Nationwide
6 Oct 2021Drug	CLASS II	Lyrica CR (pregabalin) extended release tablets, 330 mg recalled	Viatris	Potency & Assay	Nationwide
22 Sep 2021Drug	CLASS III	Candesartan Cilexetil Tablets, USP 16 mg recalled by ViatrisCandesartan Cilexetil	Viatris	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.